Maria Lopez has been appointed vice president of Quality at Cytovance Biologics. Prior to joining the company, Ms. Lopez served as the site Quality head at Novartis, where she was responsible for all Quality functions at the manufacturing facility and for the continuous improvement of the site. Before Novartis, she served as director of Quality and manager of Quality Assurance at Immucor.
 
"With over 15 years of experience in the biopharm industry, Maria brings a depth of experience in medical device and biologics manufacturing," said Darren Head, president and chief executive officer of Cytovance Biologics. "We are very fortunate to have such a well-seasoned and experienced executive join our team. Maria's knowledge and leadership skills will be tremendous assets to the company."
 
Bill Minshall, Cytovance’s most recent senior vice president of Quality Systems, has assumed a new role as senior vice president of Regulatory Affairs. His focus will be to coordinate, prepare and manage Cytovance and client regulatory submissions to ensure timely approvals.